Berrin Tunca

Summary

Affiliation: Uludag University
Country: Turkey

Publications

  1. Tunca B, Erisen L, Coskun H, Cecener G, Ozuysal S, Egeli U. P53 gene mutations in surgical margins and primary tumor tissues of patients with squamous cell carcinoma of the head and neck. Tumori. 2007;93:182-8 pubmed
    ..p53 mutations in primary tumors, the effect of the mutations on some clinical and pathological features of head and neck squamous cell carcinoma, and the impact of p53 mutations in the surgical margins on local recurrence were determined,..
  2. Tunca B, Egeli U, Cecener G, Tezcan G, Gokgoz S, Tasdelen I, et al. CK19, CK20, EGFR and HER2 status of circulating tumor cells in patients with breast cancer. Tumori. 2012;98:243-51 pubmed publisher
    ..The aims of the current study were to analyze circulating tumor cells in the blood of breast cancer patients by investigating EGFR, CK19, CK20 and HER2 expression profiles and to evaluate their prognostic importance...
  3. Tunca B, Tezcan G, Cecener G, Egeli U, Ak S, Malyer H, et al. Olea europaea leaf extract alters microRNA expression in human glioblastoma cells. J Cancer Res Clin Oncol. 2012;138:1831-44 pubmed publisher
    ..The present study aimed to evaluate whether Olea europaea leaf extract (OLE) has an anticancer effect and modulates miRNA expression in GBM...
  4. Tunca B, Tezcan G, Cecener G, Egeli U, Zorluoglu A, Yilmazlar T, et al. Overexpression of CK20, MAP3K8 and EIF5A correlates with poor prognosis in early-onset colorectal cancer patients. J Cancer Res Clin Oncol. 2013;139:691-702 pubmed publisher
    ..Further studies and validations are required; these genes may provide novel therapeutic molecular targets for CRC treatment, as well as new directions for the development of anticancer drugs. ..

Detail Information

Publications4

  1. Tunca B, Erisen L, Coskun H, Cecener G, Ozuysal S, Egeli U. P53 gene mutations in surgical margins and primary tumor tissues of patients with squamous cell carcinoma of the head and neck. Tumori. 2007;93:182-8 pubmed
    ..p53 mutations in primary tumors, the effect of the mutations on some clinical and pathological features of head and neck squamous cell carcinoma, and the impact of p53 mutations in the surgical margins on local recurrence were determined,..
  2. Tunca B, Egeli U, Cecener G, Tezcan G, Gokgoz S, Tasdelen I, et al. CK19, CK20, EGFR and HER2 status of circulating tumor cells in patients with breast cancer. Tumori. 2012;98:243-51 pubmed publisher
    ..The aims of the current study were to analyze circulating tumor cells in the blood of breast cancer patients by investigating EGFR, CK19, CK20 and HER2 expression profiles and to evaluate their prognostic importance...
  3. Tunca B, Tezcan G, Cecener G, Egeli U, Ak S, Malyer H, et al. Olea europaea leaf extract alters microRNA expression in human glioblastoma cells. J Cancer Res Clin Oncol. 2012;138:1831-44 pubmed publisher
    ..The present study aimed to evaluate whether Olea europaea leaf extract (OLE) has an anticancer effect and modulates miRNA expression in GBM...
  4. Tunca B, Tezcan G, Cecener G, Egeli U, Zorluoglu A, Yilmazlar T, et al. Overexpression of CK20, MAP3K8 and EIF5A correlates with poor prognosis in early-onset colorectal cancer patients. J Cancer Res Clin Oncol. 2013;139:691-702 pubmed publisher
    ..Further studies and validations are required; these genes may provide novel therapeutic molecular targets for CRC treatment, as well as new directions for the development of anticancer drugs. ..